{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:57:58Z","timestamp":1792706278215,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K11872"],"award-info":[{"award-number":["16K11872"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We report the first protocol for a multicenter, randomized comparison study to compare the efficacies of periodontal scaling and root-planing treatment against that of tooth-brushing treatment for nonalcoholic fatty liver disease (NAFLD) (PERION: PERIOdontal treatment for NAFLD). Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD, which can progress to cirrhosis and hepatocellular carcinoma. Increased endotoxemia is associated with the progression of NAFLD. Periodontal bacteria possess endotoxins; <jats:italic>Porphyromonas gingivalis<\/jats:italic> is well-known as a major pathogenic bacterium in periodontitis, and serum antibody levels for <jats:italic>P. gingivalis<\/jats:italic> are high in patients with periodontitis. Several reports have indicated that <jats:italic>P. gingivalis<\/jats:italic> is related to NAFLD. This study aims to investigate the effect of periodontal treatment for liver damage, <jats:italic>P. gingivalis<\/jats:italic> infection, and endotoxemia on patients with NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We will include adult patients (20\u201385\u2009years old) with NAFLD, alanine aminotransferase (ALT) \u2265\u200940\u2009IU\/L, and equivalent steatosis grade\u2009\u2265\u20091 (target sample size, <jats:italic>n<\/jats:italic>\u2009=\u200940 patients; planned number of patients with outcome data, <jats:italic>n<\/jats:italic>\u2009=\u200932). Participants will be randomly assigned to one of two groups: a scaling and root-planing group or tooth-brushing as the usual group. The primary outcome will be the change in ALT levels from baseline to 12\u2009weeks; the key secondary outcome will be the change in the serum immunoglobulin G (IgG) antibody titer for <jats:italic>P. gingivalis<\/jats:italic> at 12\u2009weeks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study should determine whether periodontal treatment decreases liver damage, <jats:italic>P. gingivalis<\/jats:italic> infection, and endotoxemia in patients with NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>University Hospital Medical Information Network (UMIN) Clinical Trials Registry, ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.umin.ac.jp\">UMIN000022079<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-020-4201-y","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T13:04:09Z","timestamp":1584968649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Yohei","family":"Kamata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Kessoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Kurihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syotaro","family":"Kuraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Takashiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobushiro","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Higurashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Taguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Usuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Minabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"4201_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cld.2009.07.007","volume":"13","author":"JM Page","year":"2009","unstructured":"Page JM, Harrison SA. NASH, and HCC. Clin Liver Dis. 2009;13:631\u201347.","journal-title":"Clin Liver Dis"},{"key":"4201_CR2","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","volume":"22","author":"S Jimba","year":"2005","unstructured":"Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005;22:1141\u20135.","journal-title":"Diabet Med"},{"key":"4201_CR3","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1185\/03007995.2010.506375","volume":"26","author":"A Sanyal","year":"2010","unstructured":"Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010;26:2183\u201391.","journal-title":"Curr Med Res Opin"},{"key":"4201_CR4","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","volume":"256","author":"VG Agopian","year":"2012","unstructured":"Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256:624\u201333.","journal-title":"Ann Surg"},{"key":"4201_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/0022034512457373","volume":"91","author":"PI Eke","year":"2012","unstructured":"Eke PI, Dye BA, Wei L, Thornton-Evans GO, Genco RJ. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012;91:914\u201320.","journal-title":"J Dent Res"},{"key":"4201_CR6","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1128\/JCM.43.11.5721-5732.2005","volume":"43","author":"JA Aas","year":"2005","unstructured":"Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Micorbiol. 2005;43:5721\u201332.","journal-title":"J Clin Micorbiol"},{"key":"4201_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.patbio.2006.07.045","volume":"55","author":"C Bodet","year":"2007","unstructured":"Bodet C, Chandad F, Grenier D. Pathogenic potential of Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, the red bacterial complex associated with periodontitis. Pathol Biol (Paris). 2007;55:154\u201362.","journal-title":"Pathol Biol (Paris)"},{"key":"4201_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/0022034514542468","volume":"93","author":"PJ Perez-Chaparro","year":"2014","unstructured":"Perez-Chaparro PJ, Gon\u00e7alves C, Figueiredo LC, Faveri M, Lob\u00e3o E, Tamashiro N, et al. Newly identified pathogens associated with periodontitis: a systematic review. J Dent Res. 2014;93:846\u201358.","journal-title":"J Dent Res"},{"key":"4201_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-0757.1999.tb00162.x","volume":"20","author":"SC Holt","year":"1999","unstructured":"Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000. 1999;20:168\u2013238.","journal-title":"Periodontol 2000"},{"key":"4201_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fmicb.2016.00053","volume":"7","author":"KY How","year":"2016","unstructured":"How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016;7:53.","journal-title":"Front Microbiol"},{"key":"4201_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039224","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Li H, Yang MF, Shu W, Sun MJ, Xu Y. Effects of aging on endotoxin tolerance induced by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. PLoS One. 2012;7:e39224.","journal-title":"PLoS One"},{"key":"4201_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4049\/jimmunol.1003252","volume":"186","author":"S Liang","year":"2011","unstructured":"Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol. 2011;186:869\u201377.","journal-title":"J Immunol"},{"key":"4201_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10266-017-0322-5","volume":"106","author":"R Kuraji","year":"2018","unstructured":"Kuraji R, Fujita M, Ito H, Hashimoto S, Numabe Y. Effects of experimental periodontitis on the metabolic system in rats with diet-induced obesity (DIO): an analysis of serum biochemical parameters. Odontology. 2018;106:162\u201370.","journal-title":"Odontology"},{"key":"4201_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00535-017-1368-4","volume":"53","author":"T Nakahara","year":"2018","unstructured":"Nakahara T, Hyogo H, Ono A, Nagaoki Y, Kawaoka T, Miki D, et al. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. J Gastroenterol. 2018;53:269\u201380.","journal-title":"J Gastroenterol"},{"key":"4201_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-230X-12-16","volume":"12","author":"M Yoneda","year":"2012","unstructured":"Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012;12:16.","journal-title":"BMC Gastroenterol"},{"key":"4201_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","volume":"46","author":"H Park","year":"2011","unstructured":"Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, et al. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:101\u20137.","journal-title":"J Gastroenterol"},{"key":"4201_CR17","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. New Eng J Med. 2010;362:1675\u201385.","journal-title":"New Eng J Med"},{"key":"4201_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/j.1478-3231.2006.01362.x","volume":"26","author":"A Suzuki","year":"2006","unstructured":"Suzuki A, Lymp J, St Sauver J, Angulo P, Lindor K. Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis. Liver Int. 2006;26:1209\u201316.","journal-title":"Liver Int"},{"key":"4201_CR19","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0022034512461796","volume":"91","author":"C Kudo","year":"2012","unstructured":"Kudo C, Naruishi K, Maeda H, Abiko Y, Hino T, Iwata M, et al. Assessment of the plasma\/serum IgG test to screen for periodontitis. J Dent Res. 2012;91:1190\u20135.","journal-title":"J Dent Res"},{"key":"4201_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1902\/jop.2011.117001","volume":"82","author":"American Academy of Periodontology","year":"2011","unstructured":"American Academy of Periodontology. Comprehensive periodontal therapy: a statement by the American Academy of Periodontology*. J Periodontol. 2011;82:943\u20139.","journal-title":"J Periodontol"},{"key":"4201_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/hep.24376","volume":"54","author":"AJ Sanyal","year":"2011","unstructured":"Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344\u201353.","journal-title":"Hepatology"},{"key":"4201_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.27678","volume":"61","author":"AJ Sanyal","year":"2015","unstructured":"Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L. Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop. Hepatology. 2015;61:1392\u2013405.","journal-title":"Hepatology"},{"key":"4201_CR23","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015;385:956\u201365.","journal-title":"Lancet"},{"key":"4201_CR24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","volume":"150","author":"V Ratziu","year":"2016","unstructured":"Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, et al. Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening. Gastroenterology. 2016;150:1147\u201359.","journal-title":"Gastroenterology"},{"key":"4201_CR25","first-page":"823","volume":"26","author":"JF Cadranel","year":"2002","unstructured":"Cadranel JF. Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol Clin Biol. 2002;26:823\u20134.","journal-title":"Gastroenterol Clin Biol"},{"key":"4201_CR26","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898\u2013906.","journal-title":"Gastroenterology"},{"key":"4201_CR27","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, et al. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36:1825\u201335.","journal-title":"Ultrasound Med Biol"},{"key":"4201_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s00535-008-2225-2","volume":"43","author":"N Obara","year":"2008","unstructured":"Obara N, Ueno Y, Fukushima K, Nakagome Y, Kakazu E, Kimura O, et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol. 2008;43:720\u20138.","journal-title":"J Gastroenterol"},{"key":"4201_CR29","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/hep.23345","volume":"50","author":"A Alisi","year":"2009","unstructured":"Alisi A, Pinzani M, Nobili V. Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease. Hepatology. 2009;50:2048\u20139 author reply 2049-50.","journal-title":"Hepatology"},{"key":"4201_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2036.2008.03711.x","volume":"28","author":"PE Chang","year":"2008","unstructured":"Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, Tan CK, et al. Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Pharmacol Ther. 2008;28:51\u201361.","journal-title":"Aliment Pharmacol Ther"},{"key":"4201_CR31","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jgh.12557","volume":"29","author":"WK Chan","year":"2014","unstructured":"Chan WK, Nik Mustapha NR, Mahadeva S. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2014;29:1470\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"4201_CR32","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","volume":"60","author":"V de L\u00e9dinghen","year":"2014","unstructured":"de L\u00e9dinghen V, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C, et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol. 2014;60:1026\u201331.","journal-title":"J Hepatol"},{"key":"4201_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/jmri.21751","volume":"29","author":"SB Reeder","year":"2009","unstructured":"Reeder SB, Robson PM, Yu H, Shimakawa A, Hines CD, McKenzie CA, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging. 2009;29:1332\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"4201_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","volume":"36","author":"Z Permutt","year":"2012","unstructured":"Permutt Z, Le TA, Peterson MR, Seki E, Brenner DA, Sirlin C, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease \u2013 MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther. 2012;36:22\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"4201_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626\u201337.","journal-title":"Gastroenterology"},{"key":"4201_CR36","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1136\/gut.2007.126417","volume":"56","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, et al. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut. 2007;56:1330\u20131.","journal-title":"Gut."},{"key":"4201_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/00016350903291913","volume":"68","author":"M Furuta","year":"2010","unstructured":"Furuta M, Ekuni D, Yamamoto T, Irie K, Koyama R, Sanbe T, et al. Relationship between periodontitis and hepatic abnormalities in young adults. Acta Odontol Scand. 2010;68:27\u201333.","journal-title":"Acta Odontol Scand"},{"key":"4201_CR38","first-page":"89","volume":"8","author":"T Saito","year":"2006","unstructured":"Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A. Relationship between periodontitis and hepatic condition in Japanese women. J Int Acad Periodontol. 2006;8:89\u201395.","journal-title":"J Int Acad Periodontol"},{"key":"4201_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2334\/josnusd.57.335","volume":"57","author":"A Ahmad","year":"2015","unstructured":"Ahmad A, Furuta M, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, et al. Association of periodontal status with liver abnormalities and metabolic syndrome. J Oral Sci. 2015;57:335\u201343.","journal-title":"J Oral Sci"},{"key":"4201_CR40","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.12659\/MSM.891204","volume":"20","author":"T Morita","year":"2014","unstructured":"Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, Nishinoue N, et al. Serum \u03b3-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults. Med Sci Monit. 2014;20:2109\u201316.","journal-title":"Med Sci Monit"},{"key":"4201_CR41","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00535-012-0738-1","volume":"48","author":"H Furusho","year":"2013","unstructured":"Furusho H, Miyauchi M, Hyogo H, Inubushi T, Ao M, Ouhara K, et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice. J Gastroenterol. 2013;48:1259\u201370.","journal-title":"J Gastroenterol"},{"key":"4201_CR42","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1038\/srep04828","volume":"4","author":"K Arimatsu","year":"2014","unstructured":"Arimatsu K, Yamada H, Miyazawa H, Minagawa T, Nakajima M, Ryder MI, et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep. 2014;4:4828.","journal-title":"Sci Rep"},{"key":"4201_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134234","volume":"10","author":"M Nakajima","year":"2015","unstructured":"Nakajima M, Arimatsu K, Kato T, Matsuda Y, Minagawa T, Takahashi N, et al. Oral administration of P gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PloS One. 2015;10:e0134234.","journal-title":"PloS One"},{"key":"4201_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/jre.12344","volume":"51","author":"Y Matsuda","year":"2016","unstructured":"Matsuda Y, Kato T, Takahashi N, Nakajima M, Arimatsu K, Minagawa T, et al. Ligature-induced periodontitis in mice induces elevated levels of circulating interleukin-6 but shows only weak effects on adipose and liver tissues. J Periodontal Res. 2016;51:639\u201346.","journal-title":"J Periodontal Res"},{"key":"4201_CR45","first-page":"298","volume":"36","author":"The Helsinki Declaration of the World Medical Association (WMA)","year":"2014","unstructured":"The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects. Pol Merkur Lekarski. 2014;36:298\u2013301.","journal-title":"Pol Merkur Lekarski"},{"key":"4201_CR46","first-page":"1055","volume":"59","author":"Y Miyazawa","year":"2011","unstructured":"Miyazawa Y. Diagnostic tests approved by Ministry of Health and Welfare (September\/October 2011). Rinsho Byori. 2011;59:1055\u201362.","journal-title":"Rinsho Byori"},{"key":"4201_CR47","doi-asserted-by":"publisher","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","volume":"152","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Inter Med. 2010;152:726\u201332.","journal-title":"Ann Inter Med"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-4201-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4201-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:19:59Z","timestamp":1616458799000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-4201-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4201"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-4201-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"5 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol conforms to the Helsinki Declaration [] and the Ethics Guidelines for Clinical Research notified by the Ministry of Health, Labor, and Welfare, Japan []. The study is projected and organized according to the Consolidated Standards of Reporting Trials 2010 guidelines []. This trial is registered at the University Hospital Medical Information Network (UMIN) Clinical Trials Registry as UMIN000022079. The study protocol was recognized by the Ethics Committees of Kanagawa Dental University, Kanagawa Dental University Yokohama Clinic, Iwasaki Internal Medicine Clinic, Yokohama City University Hospital, and Okayama University. The protocol and informed consent forms were accepted by the Ethics Committee at each of the participating institutions. Informed consent will be obtained from all participants prior to registration. During and after the trial, we are committed to complying with the requirements of all Institutional Review Boards\/Independent Ethics Committees.The Ethics Committee of Kanagawa Dental University Hospital approved the study protocol on 21 August 2015. This trial is registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (unique ID: UMIN000022079, date of registration: 15 July, 2015). Written informed consent will be obtained from all participants before enrollment. The protocol and any information supplied to gain informed consent were approved by a qualified Institutional Review Board\/Independent Ethics Committee prior to subject enrollment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"291"}}